期刊文献+

纳美芬治疗急性酒精中毒疗效分析 被引量:6

Efficacy analysis of nalmefene on acute alcoholism
原文传递
导出
摘要 目的分析纳美芬在治疗急性酒精中毒患者中的疗效及安全性。方法将2009年4月至2010年4月收治的120例急性酒精中毒患者随机分成对照组和治疗组,其身体状况、饮酒情况等差异均无统计学意义。两组在常规治疗的基础上,对照组兴奋期和共济失调期、昏迷期分别给予纳洛酮0.8 mg、1.2 mg加入0.9%氯化钠液250 ml静脉滴注,严重者需重复用药;治疗组兴奋期和共济失调期、昏迷期分别给予纳美芬0.1 mg、0.2 mg加入0.9%氯化钠液250 ml中静脉滴注。观察患者意识恢复、语言能力、共济失调及不良反应情况。结果在2 h和5 h内,两组的治愈率和总有效率相比,差异有统计学意义。结论纳美芬在治疗急性酒精中毒中疗效显著,作用时间长,不良反应少,安全可靠。 Objective To analyze the efficacy and safety for nalmefene treatment of acute alcoholism.Methods From April 2009 to April 2010,120 patients with acute alcoholism were randomly divided into control group and treatment group.There were no sigificant differences in physical condition,alcohol consumption.On the basis of conventional therapy,the control group in excitement period,ataxia period and coma period were given naloxone 0.8 mg,1.2 mg adding to 250 ml of 0.9% sodium chloride for intravenous infusion,medication was repeated in severe cases;the treatment group in excitement period and ataxia period,coma period were given nalmefene 0.1 mg,0.2 mg adding to 250 ml of 0.9% sodium chloride for intravenous infusion.The recovery of consciousness,language skills,ataxia and adverse reactions were observed.Results There were significant differences in the cure rates and total effective rates between the two groups within 2 h and 5 h.Conclusion Nalmefene in the treatment of acute alcoholism is effective,has long duration of action,with few side effects,and is safe and reliable.
出处 《临床医学》 CAS 2012年第4期8-10,共3页 Clinical Medicine
关键词 纳美芬 纳洛酮 急性酒精中毒 Nalmefene Naloxone Acute alcoholism
  • 相关文献

参考文献5

二级参考文献44

  • 1任爱国.纳美芬的药理作用及临床应用概况[J].解放军医学情报,1996,10(2):66-68. 被引量:39
  • 2谭跃 赵胜利 等.纳洛酮在肝硬化合并肝昏迷中的作用[J].中国急救医学,2000,20(7):421-421.
  • 3Rosen DA, Morris JL, Rosen KR, et al. Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study [J]. Pharmacotherapy, 2000, 20 (7): 745-9.
  • 4Li P, Chen X, Dai X, et al. Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 852(1-2): 479-84.
  • 5Veng Pedersen P, Wilhelm JA, Zakszewski TB, et al. Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmaeodynamic comparison [ J ]. J Pharm Sci, 1995, 84(9): 1101-6.
  • 6Frye RF, Matzke GR, Jallad NS, et al. The effect of age on the pharmacokineties of the opioid antagonist nalmefene [J ]. Br J Clin Pharmacol, 1996, 42(3): 301-6.
  • 7Matzke GR, Frye RF, Alexander AC, et al. The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene[J]. J Clin Pharmacol, 1996, 36(2): 144-51.
  • 8严盛芳 孙继明 陈雯.纳洛酮治疗氟乙胺中毒的报告[J].中国急救医学,2000,20:367-367.
  • 9Pert CB, Kuhar MJ, Snyder SH. Opiate receptor: autoradiographic localization in rat brain [ J]. Proc Natl Acad Sci USA, 1976, 73 (10) :3729-3733.
  • 10Martin WR. Multiple opioid receptors: a little about their history and some implications related to evolution [ J ] . Life Sci, 1981, 28 (14) : 1547-1554.

共引文献101

同被引文献47

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部